B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HSF1

MOLECULAR TARGET

heat shock factor 1

UniProt: AAH94064NCBI Gene: 1549917 compounds

HSF1 (heat shock factor 1) is targeted by 17 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HSF1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Anisomycin1.795
2celastrol1.614
3Tubercidin1.614
419-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]1.393
5Lamivudine1.102
6Piracetam0.691
7Quercetin0.691
8cycloheximide0.691
9gamma-Aminobutyric Acid0.691
10Homoharringtonine Semisynthetic derivative of harringtonine that acts as0.691
11Masoprocol0.691
12Phentolamine0.691
13Podophyllotoxin0.691
14Procaine0.691
15Torsemide0.691
16Tripterygium0.691
17xylose0.691

About HSF1 as a Drug Target

HSF1 (heat shock factor 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 17 compounds with documented HSF1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HSF1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.